日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Role of Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure Management: The Continuing Challenge of Clinical Outcome Endpoints in Heart Failure Trials

钠-葡萄糖协同转运蛋白2抑制剂在心力衰竭治疗中的作用:心力衰竭试验中临床结局终点的持续挑战

Ji, Luxi; Mishra, Mudit; De Geest, Bart

New Perspectives on Cholesterol and Lipoprotein Metabolism

胆固醇和脂蛋白代谢的新视角

De Geest, Bart; Mishra, Mudit

Structured LDH/Bentonite Composites for Chromium Removal and Recovery from Aqueous Solutions

结构化 LDH/膨润土复合材料用于从水溶液中去除和回收铬

Mitra De Geest, Bart Michielsen, Radu-G Ciocarlan, Pegie Cool, Elena M Seftel

Impact of High-Density Lipoproteins on Sepsis

高密度脂蛋白对脓毒症的影响

De Geest, Bart; Mishra, Mudit

Doxorubicin-induced cardiomyopathy: TERT gets to the heart of the matter

多柔比星诱发的心肌病:TERT 直击问题核心

De Geest, Bart; Mishra, Mudit

Role of Oxidative Stress in Heart Failure: Insights from Gene Transfer Studies

氧化应激在心力衰竭中的作用:来自基因转移研究的启示

De Geest, Bart; Mishra, Mudit

High-Density Lipoprotein-Targeted Therapies for Heart Failure

针对心力衰竭的高密度脂蛋白靶向疗法

Mishra, Mudit; De Geest, Bart

Cholesterol-Lowering Gene Therapy Prevents Heart Failure with Preserved Ejection Fraction in Obese Type 2 Diabetic Mice

降低胆固醇的基因疗法可预防肥胖型2型糖尿病小鼠发生射血分数保留型心力衰竭

Aboumsallem, Joseph Pierre; Muthuramu, Ilayaraja; Mishra, Mudit; De Geest, Bart

Reconstituted HDL (Milano) Treatment Efficaciously Reverses Heart Failure with Preserved Ejection Fraction in Mice

重组高密度脂蛋白(米兰)治疗可有效逆转小鼠射血分数保留型心力衰竭

Mishra, Mudit; Muthuramu, Ilayaraja; Aboumsallem, Joseph Pierre; Kempen, Herman; De Geest, Bart

Selective HDL-Raising Human Apo A-I Gene Therapy Counteracts Cardiac Hypertrophy, Reduces Myocardial Fibrosis, and Improves Cardiac Function in Mice with Chronic Pressure Overload

选择性提高高密度脂蛋白胆固醇(HDL)水平的人类载脂蛋白AI基因疗法可对抗慢性压力超负荷小鼠的心脏肥大,减少心肌纤维化,并改善心脏功能。

Amin, Ruhul; Muthuramu, Ilayaraja; Aboumsallem, Joseph Pierre; Mishra, Mudit; Jacobs, Frank; De Geest, Bart